Choose a language and wait for the translated text.
Shots:
The US FDA has cleared Medtronic’s Hugo robotic-assisted surgery (RAS) system for use in general surgery procedures, via an expanded 510(k)
The clearance covers all upper abdominal general surgical procedures, incl. cholecystectomy, Roux-en-Y gastric bypass, ventral hernia & small bowel resection, plus lower abdominal inguinal hernia repair & appendectomy; together these account for ~3.5M US surgeries annually
The indication expands Hugo’s US use beyond urology; the system is in clinical use at a growing number of US hospitals, with global procedure growth running at more than 2x the robotic surgery market and on track to surpass 50,000 procedures by the end of Medtronic’s fiscal year
Ref: Medtronic | Image: Medtronic | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
The post The US FDA Clears Medtronic’s Hugo RAS System for General Surgery Procedures appeared first on PharmaShots.